FIIs expected to increase allocations in India due to clear growth visibility. Budget 2024 may focus on capex, indigenisation, and manufacturing. Defence, railways, power, capital goods, and real estate likely to be in focus. Pharma sector seeing a rally due to stable pricing environment and expectations of favourable generic pricing in 2024. Investors should focus on remaining invested and sticking to planned asset allocation.
| Subscribe To Our Free Newsletter |
